Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2013-06-15 16:56:51 UTC
Update Date2021-09-14 15:39:04 UTC
HMDB IDHMDB0060568
Secondary Accession Numbers
  • HMDB0060674
  • HMDB60568
  • HMDB60674
Metabolite Identification
Common Name10,11-Dihydroxycarbamazepine
Description10,11-Dihydroxycarbamazepine, also called carbamazepine diol, is a metabolite of both carbamazepine and oxcarbazepine. Carbamazepine (CBZ) is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia. Oxcarbazepine is an anticonvulsant and mood-stabilizing drug, used primarily in the treatment of epilepsy. It is also used to treat anxiety and mood disorders, and benign motor tics. (Wikipedia)
Structure
Data?1563866077
Synonyms
ValueSource
(-)-(S,S)-trans-10,11-Dihydro-10,11-dihydroxy-5H-dibenzo[b,F]azepine-5-carboxamideChEBI
10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide, (cis)-isomerHMDB
10,11-Dihydroxy-10,11-dihydrocarbamazepineHMDB
10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide, (10S,trans)-isomerHMDB
10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide, (trans)-isomerHMDB
10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide, (trans-(+-))-isomerHMDB
10,11-Dihydro-10,11-dihydroxycarbamazepineHMDB
Carbazepine 10,11-diolHMDB
CBZ-DiolHMDB
10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamideHMDB
10,11-Dihydro-10,11-transdihydroxycarbamazepineHMDB
CBZDHMDB
Carbamazepine-10,11-diolHMDB
Carbamazepine-10,11-transdiolHMDB
Chemical FormulaC15H14N2O3
Average Molecular Weight270.2833
Monoisotopic Molecular Weight270.100442324
IUPAC Name(9S,10S)-9,10-dihydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboximidic acid
Traditional Name(9S,10S)-9,10-dihydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboximidic acid
CAS Registry NumberNot Available
SMILES
O[C@@H]1[C@@H](O)C2=CC=CC=C2N(C(O)=N)C2=CC=CC=C12
InChI Identifier
InChI=1S/C15H14N2O3/c16-15(20)17-11-7-3-1-5-9(11)13(18)14(19)10-6-2-4-8-12(10)17/h1-8,13-14,18-19H,(H2,16,20)/t13-,14-/m0/s1
InChI KeyPRGQOPPDPVELEG-KBPBESRZSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzazepines
Sub ClassDibenzazepines
Direct ParentDibenzazepines
Alternative Parents
Substituents
  • Dibenzazepine
  • Azepine
  • Benzenoid
  • 1,2-diol
  • Isourea
  • Secondary alcohol
  • Carboximidic acid derivative
  • Azacycle
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Imine
  • Organopnictogen compound
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organooxygen compound
  • Alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
  • 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine (CHEBI:83815 )
Ontology
Not AvailableNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.3 g/LALOGPS
logP0.64ALOGPS
logP1.79ChemAxon
logS-3ALOGPS
pKa (Strongest Acidic)8.24ChemAxon
pKa (Strongest Basic)3.86ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area87.78 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity84.73 m³·mol⁻¹ChemAxon
Polarizability27.5 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+160.34531661259
DarkChem[M-H]-156.48831661259
DeepCCS[M-2H]-193.03530932474
DeepCCS[M+Na]+168.19630932474
AllCCS[M+H]+163.032859911
AllCCS[M+H-H2O]+159.232859911
AllCCS[M+NH4]+166.632859911
AllCCS[M+Na]+167.632859911
AllCCS[M-H]-163.632859911
AllCCS[M+Na-2H]-163.032859911
AllCCS[M+HCOO]-162.632859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022.2.65 minutes32390414
Predicted by Siyang on May 30, 202210.3976 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20223.48 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1451.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid241.5 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid115.2 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid171.6 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid57.2 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid271.4 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid407.9 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)220.7 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid700.9 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid219.3 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1169.4 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid213.3 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid241.5 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate322.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA208.6 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water78.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
10,11-DihydroxycarbamazepineO[C@@H]1[C@@H](O)C2=CC=CC=C2N(C(O)=N)C2=CC=CC=C124116.4Standard polar33892256
10,11-DihydroxycarbamazepineO[C@@H]1[C@@H](O)C2=CC=CC=C2N(C(O)=N)C2=CC=CC=C122662.2Standard non polar33892256
10,11-DihydroxycarbamazepineO[C@@H]1[C@@H](O)C2=CC=CC=C2N(C(O)=N)C2=CC=CC=C122701.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
10,11-Dihydroxycarbamazepine,1TMS,isomer #1C[Si](C)(C)O[C@H]1C2=CC=CC=C2N(C(=N)O)C2=CC=CC=C2[C@@H]1O2453.4Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,1TMS,isomer #2C[Si](C)(C)OC(=N)N1C2=CC=CC=C2[C@H](O)[C@@H](O)C2=CC=CC=C212413.7Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,1TMS,isomer #3C[Si](C)(C)N=C(O)N1C2=CC=CC=C2[C@H](O)[C@@H](O)C2=CC=CC=C212417.1Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TMS,isomer #1C[Si](C)(C)OC(=N)N1C2=CC=CC=C2[C@H](O)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212416.9Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TMS,isomer #2C[Si](C)(C)O[C@H]1C2=CC=CC=C2N(C(=N)O)C2=CC=CC=C2[C@@H]1O[Si](C)(C)C2461.0Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TMS,isomer #3C[Si](C)(C)N=C(O)N1C2=CC=CC=C2[C@H](O)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212401.2Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TMS,isomer #4C[Si](C)(C)N=C(O[Si](C)(C)C)N1C2=CC=CC=C2[C@H](O)[C@@H](O)C2=CC=CC=C212399.1Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,3TMS,isomer #1C[Si](C)(C)OC(=N)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212476.8Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,3TMS,isomer #2C[Si](C)(C)N=C(O[Si](C)(C)C)N1C2=CC=CC=C2[C@H](O)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212441.1Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,3TMS,isomer #3C[Si](C)(C)N=C(O)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212422.1Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,4TMS,isomer #1C[Si](C)(C)N=C(O[Si](C)(C)C)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212506.6Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,4TMS,isomer #1C[Si](C)(C)N=C(O[Si](C)(C)C)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212463.3Standard non polar33892256
10,11-Dihydroxycarbamazepine,4TMS,isomer #1C[Si](C)(C)N=C(O[Si](C)(C)C)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C2=CC=CC=C212906.5Standard polar33892256
10,11-Dihydroxycarbamazepine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)O[C@H]1C2=CC=CC=C2N(C(=N)O)C2=CC=CC=C2[C@@H]1O2670.1Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=N)N1C2=CC=CC=C2[C@H](O)[C@@H](O)C2=CC=CC=C212629.6Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(O)N1C2=CC=CC=C2[C@H](O)[C@@H](O)C2=CC=CC=C212706.0Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)N1C2=CC=CC=C2[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212770.6Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)O[C@H]1C2=CC=CC=C2N(C(=N)O)C2=CC=CC=C2[C@@H]1O[Si](C)(C)C(C)(C)C2840.8Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(O)N1C2=CC=CC=C2[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212807.8Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)N1C2=CC=CC=C2[C@H](O)[C@@H](O)C2=CC=CC=C212817.7Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212978.0Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)N1C2=CC=CC=C2[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212983.5Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(O)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C212986.2Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C213172.1Semi standard non polar33892256
10,11-Dihydroxycarbamazepine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C213218.8Standard non polar33892256
10,11-Dihydroxycarbamazepine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N=C(O[Si](C)(C)C(C)(C)C)N1C2=CC=CC=C2[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C2=CC=CC=C213257.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 10,11-Dihydroxycarbamazepine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-0920000000-eb6cb3a799bd4e70259e2017-09-20Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 10,11-Dihydroxycarbamazepine GC-MS (3 TMS) - 70eV, Positivesplash10-00di-5139500000-4a965c4fd4ff46c9d08d2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 10,11-Dihydroxycarbamazepine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-QTOF , positive-QTOFsplash10-0udi-0090000000-582fa58dfe799f555f7d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-QTOF , positive-QTOFsplash10-01q9-0690000000-ea921c1070d79fb8606b2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-QTOF , positive-QTOFsplash10-001i-0920000000-2acc6feb8a821792f63a2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-QTOF , positive-QTOFsplash10-001i-0900000000-2eb3eaf74be1cde9934d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-QTOF , positive-QTOFsplash10-001i-0900000000-908137ed979bd5990aa92017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-0udi-0090000000-a69751368f3b9c28fded2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-0udi-0090000000-dc082f0f810c6badb8662017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-03ei-0290000000-ba77117c6385c4c74ea42017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0940000000-da3e00b58237cb4d13f42017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0910000000-5a8824ed936b14eb24182017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0900000000-049f0081a61bf95d3dc12017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0900000000-91fcce62da1e3e5de2292017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-0udi-0090000000-cf5c813c71e73c67b3902017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-03ei-0290000000-6e3b8b98af2b87ded89c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0940000000-51acaa81d85d4755d1222017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0900000000-1bdf38c80976bafdecd42017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0900000000-8e6691f83ff3f5fba4a32017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-001i-0900000000-698fb78341b98e4babb52017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine LC-ESI-ITFT , positive-QTOFsplash10-0udi-0090000000-542e5ed32f92a71c0fb42017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine 10V, Positive-QTOFsplash10-00di-0090000000-5dc9806a3f24413a2bdf2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine 20V, Positive-QTOFsplash10-00b9-0090000000-2e80717b6751b35215c52016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine 40V, Positive-QTOFsplash10-08fu-4980000000-5b75ba83f596ac53f2fc2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine 10V, Negative-QTOFsplash10-00mo-5090000000-498cf604abc4e8e617b42016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine 20V, Negative-QTOFsplash10-004i-2090000000-fdedb62297622d12bae72016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10,11-Dihydroxycarbamazepine 40V, Negative-QTOFsplash10-0006-9500000000-3a4398b915fe3442ff942016-08-03Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID102714
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound114725
PDB IDNot Available
ChEBI ID83815
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available